Clinical trial
Efficacy and Safety of SPARC0921 in Subjects With Spasticity
NCT01457352 is registered in ClinicalTrials.gov with Sun Pharma Advanced Research Company Limited as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy and Safety of SPARC0921 in Subjects With Spasticity
- Lead sponsor
- Sun Pharma Advanced Research Company Limited
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- November 14, 2012
- Completion date
- August 25, 2017
- Enrollment
- 392 (actual)
- Sites
- 73
Conditions
As the registry lists them; a condition with its own page is linked.
spasticity